Sustainability of Biosimilars in Europe: A Delphi Panel Consensus with Systematic Literature Review.

Arnold G VultoJackie Vanderpuye-OrgleMartin van der GraaffSteven R A SimoensLorenzo DagnaRichard MacaulayBeenish MajeedJeffrey LemayJane HippenmeyerSebastian Gonzalez-McQuire

Published in: Pharmaceuticals (Basel, Switzerland) (2020)

A sustainable biosimilar market means that all stakeholders benefit from appropriate and reliable access to biological therapies. Failure to care for biosimilar market sustainability may impoverish biosimilar development and offerings, eventually leading to increased cost for health care systems and patients, with fewer resources for innovation.

Keyphrases

healthcare
health insurance
affordable care act
case report
quality improvement
clinical practice
social media
health information